These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37931375)

  • 1. Can combined high-resolution vessel wall imaging and multiple post-labeling delay 3D pseudo-continuous arterial spin labeling differentiate moyamoya disease from atherosclerotic moyamoya syndrome?
    Guo Y; Dou W; Wang X; Wang X; Mao H; Chen K
    Eur J Radiol; 2023 Dec; 169():111184. PubMed ID: 37931375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution combined arterial spin labeling MR for identifying cerebral arterial stenosis induced by moyamoya disease or atherosclerosis.
    Ya J; Zhou D; Ding J; Ding Y; Ji X; Yang Q; Meng R
    Ann Transl Med; 2020 Feb; 8(4):87. PubMed ID: 32175380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution MRI of the vessel wall helps to distinguish moyamoya disease from atherosclerotic moyamoya syndrome.
    Yang S; Wang X; Liao W; Li L; Tan Z; Zhu L; Hu P; Cui X; Xing W
    Clin Radiol; 2021 May; 76(5):392.e11-392.e19. PubMed ID: 33583567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of blood supply of the external carotid artery in moyamoya disease using super-selective pseudo-continuous arterial spin labeling technique.
    Yuan J; Qu J; Lv Z; Wu C; Zhang D; Liu X; Yang B; Liu Y
    Eur Radiol; 2021 Dec; 31(12):9287-9295. PubMed ID: 34021389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary and emerging magnetic resonance imaging methods for evaluation of moyamoya disease.
    Lehman VT; Cogswell PM; Rinaldo L; Brinjikji W; Huston J; Klaas JP; Lanzino G
    Neurosurg Focus; 2019 Dec; 47(6):E6. PubMed ID: 31786551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in cerebral blood flow measurement using arterial spin labeling MRI between patients with moyamoya disease and patients with arteriosclerotic cerebrovascular disease.
    Ueda Y; Tanaka Y; Hara S; Inaji M; Ishii K; Maehara T; Nariai T
    Acta Radiol; 2023 Jan; 64(1):311-319. PubMed ID: 35037475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-delay arterial spin labeling perfusion MRI in moyamoya disease--comparison with CT perfusion imaging.
    Wang R; Yu S; Alger JR; Zuo Z; Chen J; Wang R; An J; Wang B; Zhao J; Xue R; Wang DJ
    Eur Radiol; 2014 May; 24(5):1135-44. PubMed ID: 24557051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of CBF Measured with Combined Velocity-Selective Arterial Spin-Labeling and Pulsed Arterial Spin-Labeling to Blood Flow Patterns Assessed by Conventional Angiography in Pediatric Moyamoya.
    Bolar DS; Gagoski B; Orbach DB; Smith E; Adalsteinsson E; Rosen BR; Grant PE; Robertson RL
    AJNR Am J Neuroradiol; 2019 Nov; 40(11):1842-1849. PubMed ID: 31694821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic performance of high-resolution magnetic resonance-vessel wall imaging in differentiating atherosclerosis-associated moyamoya vasculopathy from moyamoya disease.
    Liu S; Lu M; Gao X; Wen C; Sun B; Liu Y; Han C; Hao F; Sheng F; Liu D; Zhang H; Cai J
    Eur Radiol; 2023 Oct; 33(10):6918-6926. PubMed ID: 37453985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust arterial transit time and cerebral blood flow estimation using combined acquisition of Hadamard-encoded multi-delay and long-labeled long-delay pseudo-continuous arterial spin labeling: a simulation and in vivo study.
    Ishida S; Kimura H; Isozaki M; Takei N; Fujiwara Y; Kanamoto M; Kosaka N; Matsuda T; Kidoya E
    NMR Biomed; 2020 Aug; 33(8):e4319. PubMed ID: 32424992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudo-continuous and territorial arterial spin labeling MRI for assessment of cerebral perfusion in moyamoya disease after revascularization: A comparative study with digital subtraction angiography.
    Li J; Meng Q; Huang L; Pylypenko D; Zhong H
    Heliyon; 2024 Sep; 10(17):e37368. PubMed ID: 39296041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of 3D pseudo-continuousarterial spin labeling perfusion imaging in moyamoya disease-Comparison with dynamic susceptibility contrast perfusion imaging.
    Zhang H; Lu M; Liu S; Liu D; Shen X; Sheng F; Han C; Cai J
    Front Neurosci; 2022; 16():944246. PubMed ID: 35992916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More Precise Imaging Analysis and Diagnosis of Moyamoya Disease and Moyamoya Syndrome Using High-Resolution Magnetic Resonance Imaging.
    Yu LB; He H; Zhao JZ; Wang R; Zhang Q; Shi ZY; Shao JS; Zhang D
    World Neurosurg; 2016 Dec; 96():252-260. PubMed ID: 27576769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Dimensional Arterial Spin Labeling for the Evaluation of the Cerebral Hemodynamics in Ischemic and Hemorrhagic Moyamoya Disease.
    Bian H; Zhang L; Wang J
    Cerebrovasc Dis; 2024; 53(3):307-315. PubMed ID: 37722371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.
    Quon JL; Kim LH; Lober RM; Maleki M; Steinberg GK; Yeom KW
    J Neurosurg Pediatr; 2019 Apr; 23(4):486-492. PubMed ID: 30738390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Cerebral Hemodynamics and Cognitive Function in Adult Patients with Moyamoya Disease: A Three-Dimensional Pseudo-Continuous Arterial Spin Labeling Study.
    Zha X; Liang Z; Zheng L; Xu Y
    World Neurosurg; 2023 Jul; 175():e447-e454. PubMed ID: 37024086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of 3D-PCASL combined with t-ASL and MRA in the diagnosis of patients with isolated vertigo induced by posterior circulation ischemia.
    Xie X; Mo L; Liu P; Liu C; Liu M; Deng Y; Zhang P; Yuan J; Song T; Ma L
    Magn Reson Imaging; 2024 Jul; 110():78-85. PubMed ID: 38636674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
    Togao O; Obara M; Yamashita K; Kikuchi K; Arimura K; Nishimura A; Nakamizo A; Wada T; Tokunaga C; Mikayama R; Yamashita Y; Hamano H; Van Cauteren M; Ishigami K; Baba S
    Neuroradiology; 2023 Mar; 65(3):529-538. PubMed ID: 36434310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 7.0- and 3.0-T MRI and MRA in ischemic-type moyamoya disease: preliminary experience.
    Deng X; Zhang Z; Zhang Y; Zhang D; Wang R; Ye X; Xu L; Wang B; Wang K; Zhao J
    J Neurosurg; 2016 Jun; 124(6):1716-25. PubMed ID: 26544772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of single-postlabeling delay and seven-delay three-dimensional pseudo-continuous arterial spin labeling in the assessment of intracranial atherosclerotic disease.
    Yu H; Ouyang Y; Feng Y; Sun S; Zhang L; Liu Z; Tian H; Xie S
    Quant Imaging Med Surg; 2023 Apr; 13(4):2514-2525. PubMed ID: 37064395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.